Head to Head Review: PACS Group (NYSE:PACS) and Surgery Partners (NASDAQ:SGRY)

by · The Cerbat Gem

Surgery Partners (NASDAQ:SGRY – Get Free Report) and PACS Group (NYSE:PACS – Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

Valuation and Earnings

This table compares Surgery Partners and PACS Group”s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31 billion0.92-$77.90 million($0.70)-33.04
PACS Group$5.29 billion1.39$191.54 million$1.7227.09

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Surgery Partners and PACS Group’s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Surgery Partners-2.63%0.88%0.34%
PACS Group4.85%29.55%5.23%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Surgery Partners and PACS Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Surgery Partners18302.17
PACS Group02502.71

Surgery Partners presently has a consensus target price of $20.14, suggesting a potential downside of 12.94%. PACS Group has a consensus target price of $58.80, suggesting a potential upside of 26.21%. Given PACS Group’s stronger consensus rating and higher possible upside, analysts clearly believe PACS Group is more favorable than Surgery Partners.

Risk & Volatility

Surgery Partners has a beta of 1.85, suggesting that its share price is 85% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500.

Summary

PACS Group beats Surgery Partners on 10 of the 12 factors compared between the two stocks.

About Surgery Partners

(Get Free Report)

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

About PACS Group

(Get Free Report)

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.